VACCIBODY DNA VACCINE PLATFORM VB10.NEO INDUCES STRONG NEO-ANTIGEN SPECIFIC CD8+ T CELL RESPONSES CRITICAL TO CURE ESTABLISHED TUMORS IN PRE-CLINICAL MODELS | Atlanta, April 2019
1687
portfolio_page-template-default,single,single-portfolio_page,postid-1687,bridge-core-1.0.4,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-18.0.8,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-5.7,vc_responsive

VACCIBODY DNA VACCINE PLATFORM VB10.NEO INDUCES STRONG NEO-ANTIGEN SPECIFIC CD8+ T CELL RESPONSES CRITICAL TO CURE ESTABLISHED TUMORS IN PRE-CLINICAL MODELS

Atlanta, April 2019